THE CYP2D6 'ENHANCER' SNP: LONG-RANGE LINKAGE ANALYSIS AND IMPACT ON ACTIVITY IN HUMAN LIVER TISSUE

被引：0
|
作者：
Gaedigk, Andrea [1 ]
Boone, Erin C. [1 ]
Dinh, Jean C. [1 ]
Gaedigk, Roger [1 ]
Lata, Ryan F. [1 ]
Pearce, Robin E. [1 ]
Wang, Wendy Y. [1 ]
Miller, Neil A. [1 ]
Staggs, Vincent S. [1 ]
Leeder, J. Steven [1 ]
机构：
[1] Childrens Mercy Kansas City, Kansas City, MO USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2020年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P191
引用
收藏
页码：S80 / S81
页数：3
相关论文
共 50 条
  • [41] Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice
    Cole Tolledo
    Marlaina R. Stocco
    Sharon Miksys
    Frank J. Gonzalez
    Rachel F. Tyndale
    Molecular Neurobiology, 2020, 57 : 2509 - 2520
  • [42] CYP2D6 Polymorphisms and the impact on tamoxifen therapy
    Beverage, Jacob N.
    Sissung, Tristan M.
    Sion, Amy M.
    Danesi, Romano
    Figg, William D.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (09) : 2224 - 2231
  • [43] The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
    Ferraldeschi, Roberta
    Newman, William G.
    PHARMACEUTICALS, 2010, 3 (04) : 1122 - 1138
  • [44] GENETIC POLYMORPHISM IN CYTOCHROME P450 2D6 (CYP2D6): POPULATION DISTRIBUTION OF CYP2D6 ACTIVITY
    Neafsey, Patricia
    Ginsberg, Gary
    Hattis, Dale
    Sonawane, Babasaheb
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 334 - 361
  • [45] Doxepin inhibits CYP2D6 activity in vivo
    Szewczuk-Boguslawska, M
    Kiejna, A
    Beszlej, JA
    Orzechowska-Juzwenko, K
    Milejski, P
    POLISH JOURNAL OF PHARMACOLOGY, 2004, 56 (04): : 491 - 494
  • [46] Assessment of CYP2D6 activity in depressed patients
    Szewczuk-Bogusawska, M
    Orzechowska-Juzwenko, K
    Milejski, P
    Beszlej, JA
    Grzesiak, M
    Kiejna, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S219 - S219
  • [47] CYP2D6 activity in methadone maintenance patients
    Shiran, MR
    Rostami-Hodjegan, A
    Lennard, MS
    Iqbal, MZ
    Lagundoye, O
    Pratt, P
    Seiveright, N
    Tucker, GT
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A54 - A54
  • [48] The effect of TCAs on CYP2D6 activity in vivo
    Szewczuk-Boguslawska, M.
    Kiejna, A.
    Beszlej, J.
    Orzechowska-Juzwenko, K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S251 - S251
  • [49] The use of Yohimbine for phenotyping of CYP2D6 activity
    Vay, M.
    Rose, P.
    Meyer, M.
    Mikus, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S24 - S24
  • [50] INTERINDIVIDUAL VARIABILITY IN CYP2D6 ACTIVITY IN HUMAN LIVER MICROSOMES TO CHARACTERIZE RARE GENETIC VARIATION.
    Dalton, R.
    Phillips, B.
    Risler, L.
    Shen, D. D.
    Woodahl, E. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S65 - S66
12345